London, United Kingdom
Freeda.AI, founded in 2023, is pioneering a new paradigm in menopause care with the Agentic Menopause Revolutionโข. They focus on bridging the staggering $1.5 trillion Untreated Menopause Gap caused by the lack of effective treatment accessible to women experiencing menopause.
The company's approach addresses the shortcomings of conventional digital menopause solutions. Previous digital solutions raised awareness but failed to eliminate treatment barriers due to high costs and limited scalability. By leveraging cutting-edge technology, Freeda.AI offers 24/7 one-on-one personalized guidance through its Agentic Health Catalystโข, combining infinite technology scale and human-like intelligence to redefine menopause care.
The impact of their solution is noteworthy, with an impressive 70% increase in diagnostic speed and accuracy, a 50% improvement in symptom management, and significant annual savings of $2,300-$10,000 per employee for companies.
Freeda.AI represents an attractive opportunity for investors seeking to partake in the burgeoning field of preventive health care innovation.
